Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$442,301,164
+$5,086,710 QoQ
Shares Held
2,332,566
+5.2% QoQ
Ownership
0.150%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
#60
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 73%
Shared 0%
None 27%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LAZARD ASSET MANAGEMENT LLC holds $2,100,933,315 across 14 Drug Manufacturers - General names. AZN ranks #2 (21.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
694,293 | $832,755,921 | |
| 2 | AZN |
Astrazeneca PLC
This page
|
2,332,566 | $442,301,164 | |
| 3 | JNJ |
Johnson & Johnson
|
1,364,685 | $346,589,048 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,843,591 | $236,901,443 | |
| 5 | ABBV |
AbbVie Inc.
|
254,499 | $64,042,128 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,063,855 | $61,299,324 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
284,948 | $36,000,330 | |
| 8 | NVO |
Novo Nordisk A S
|
657,641 | $31,527,309 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $442,301,164 | 2,332,566 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $437,214,454 | 2,216,887 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||